Plasma membrane translocation, following allosteric binding of second messengers, initiates the signal transduction process mediated by cPKC [conventional PKC (protein kinase C)] isotypes. Mechanisms regulating the lifespan of the active enzyme such as its phosphorylation, internalization, dephosphorylation and degradation are key elements of the signalling network. The understanding of such mechanisms is essential for the design of therapeutic strategies targeting PKC isoenzymes.
Introduction
The PKC (protein kinase C) family of serine/threonine protein kinases is widely recognized as a central element of signal transduction pathways. Conversion of extracellular signals into intracellular messages is ultimately realized by PKC through phosphorylation, and consequent modulation of activity, of a wide range of proteins implicated in cellular functions such as regulation of cell growth, cell proliferation, apoptosis and malignant transformation.
PKC isoenzymes have been classified into three groups according to their domain composition, which accounts for their differences in lipid-and calcium-binding characteristics [1] . These groups are named cPKCs (conventional PKCs; also called classical PKCs), which comprise the α, βI, βII and γ isotypes, nPKCs (novel PKCs), which include the δ, ε, η and θ isotypes, and aPKCs (atypical PKCs), which consist of the ζ and ι/λ isotypes. cPKCs are composed of an N-terminal regulatory region, comprising the C1 and C2 domains as well as an autoinhibitory pseudosubstrate peptide, and a conserved C-terminal catalytic region, the kinase core, comprising the C3 and C4 domains. C1 and C2 domains are the binding sites for the second messengers DAG (diacylglycerol) and Ca 2+ respectively. In the kinase core, the C3 domain contains the ATP-binding region, whereas the C4 domain forms the substrate-binding region. At the C-terminus, three priming sites are also located whose phosphorylation renders the enzyme catalytically competent. 
cPKC regulation
The function of cPKCs is tightly regulated by three coordinated mechanisms. First, the enzyme achieves catalytic competence by phosphorylation of its priming sites. Secondly, binding of Ca 2+ and DAG to the regulatory domains activates the enzyme by inducing its translocation to plasma membranes. The pseudosubstrate, which under resting conditions is lodged in the substrate-binding cavity and keeps cPKCs in an inactive conformation, is then disengaged. Finally, cPKC signalling is controlled by desensitization mechanisms resulting in its internalization, dephosphorylation and degradation.
Control by phosphorylation
PKCα will be taken here into consideration as a paradigm for cPKC isotypes. PKCα contains three specific phosphorylation motifs located at the C-terminus, named the activation loop site, the turn motif and the hydrophobic motif respectively. The enzyme is synthesized in the cytoplasm as an inactive precursor in an open conformation in which the autoinhibitory pseudosubstrate sequence is not occupying the substrate-binding site and the unphosphorylated activation loop is unmasked ( Figure 1A ). PKCα associates with the plasma membrane through multiple low-affinity interactions of the C1 and C2 domains to anionic lipids. In this conformation, PKCα's activation loop site is accessible to PDK1 (phosphoinositide-dependent kinase 1), which phosphorylates it at Thr 497 . This site has been shown to be essential for catalytic activity, as mutations of Thr 497 lead to inactivation of the enzyme [2] . Phosphorylation of Thr 497 triggers two subsequent autophosphorylations at the turn motif (Thr 638 ) and at the hydrophobic motif (Ser 657 ) respectively. Thr 638 phosphorylation is not required for the catalytic function of PKCα, but serves to stabilize the conformation of the enzyme and also to control the duration of activation by regulating the rate of dephosphorylation and inactivation of the protein [3] . Finally, the Ser 657 phosphorylation appears to control the accumulation of phosphate on PKCα and also contributes to the maintenance of a phosphatase-resistant (E) down-regulation of membrane-bound PKC by endosomal internalization through caveolae-dependent trafficking; (F) PKC localization to a perinuclear compartment followed by dephosphorylation; (G) dephosphorylated PKC might get directly degraded, recycled by Hsp70 or, following ubiquitination, degraded by the proteasome.
conformation of the enzyme [4] . Upon phosphorylation at its priming sites, PKCα is rendered catalytically competent and released to the cytoplasm in a closed conformation in which the inhibitory pseudosubstrate sequence blocks the substrate-binding cavity, making the enzyme inactive.
Control by membrane-targeting following binding of second messengers
Activation of cPKC requires the binding of second messengers to the C2-and C1-regulatory domains. External stimuli acting upon membrane receptors (i.e. G-protein-coupled receptors or receptor tyrosine kinases) initiate a cascade of events that includes the hydrolysis of PIP 2 (phosphatidylinositol 4,5-bisphosphate) into the Ca 2+ -mobilizing messenger IP 3 (inositol 1,4,5-trisphosphate) and DAG. An increase in the intracellular Ca 2+ concentration after IP 3 production induces Ca 2+ binding to the C2 domain of the cytosolic PKC ( Figure 1B) . The C2 domain serves as a membranetargeting molecule that binds anionic phospholipids in a Ca 2+ -dependent fashion [5] . Therefore Ca 2+ -bound cPKC by diffusing in the cytoplasm will bind, although weakly, to the plasma membrane after few collisions [6] . It will then diffuse in the plane of the membrane until it encounters a DAG molecule. Its C1 domain will bind DAG, establishing a highaffinity interaction between cPKC and the plasma membrane.
This interaction induces release of the autoinhibitory pseudosubstrate peptide from the substrate-binding site, switching cPKC to the open conformation. cPKC is now a mature active enzyme that is able to interact with its substrate and initiate the signal transduction processes.
Although cPKC translocation is a diffusional process, it does not contradict the established role of PKC-binding partners. These proteins indeed target PKC isotypes to their specific membrane compartments and bring them in close proximity to their substrates [7, 8] .
Control by desensitization mechanisms
Down-regulation of cPKC and the consequent termination of signalling are achieved by several mechanisms. Figure 1 is an attempt to unify these regulatory mechanisms of the lifespan of cPKCs in a single scheme, although all of these mechanisms are not necessarily active at the same time, in the same cell type and for all isotypes.
It is now well accepted that sustained activation of PKCα leads to dephosphorylation of its specific priming sites. The dephosphorylated enzyme is more sensitive to phosphatases, proteases and oxidation, leading to inactivation of the enzyme. Dephosphorylation has been shown to be temperature-sensitive, correlating with transient accumulation of PKCα on cytoplasmic vesicular structures and suggesting that a membrane-traffic event is involved, although the precise compartment where PKCα is dephosphorylated remains to be determined [9] .
Dephosphorylated cPKCs can be rescued from degradation ( Figure 1C ). Hsp70 (heat-shock protein 70) binds dephosphorylated PKCβII at its turn motif. In so doing, it prevents its degradation. PKCβII can be then re-phosphorylated and cycled back into the pool of functional enzymes [10] .
In a rat intestinal cell line, two distinct mechanisms of PKCα down-regulation have been shown to coexist [11] . Exposure to the PKC agonist PMA induced desensitization by ubiquitination of the fully phosphorylated enzyme at the plasma membrane and subsequent degradation at the proteasome ( Figure 1D ). Interestingly, in the same intestinal cell line, exposure to a different PKC agonist, bryostatin 1, induced PKCα desensitization not only by the ubiquitinproteasome-dependent mechanism just mentioned, but also through a caveolae-dependent internalization of the active enzyme followed by dephosphorylation and degradation ( Figure 1E ). This latest mechanism is an established downregulation pathway. PKCα has been shown in other cell types, such as MCF7, to be trafficked from the plasma membrane to an endosomal compartment through caveolae in its active phosphorylated form [12] . Active PKCα is sorted then to a Rab-11-positive perinuclear compartment [13] , where presumably it is dephosphorylated and targeted for degradation.
Ubiquitination of fully phosphorylated active PKCα followed by degradation, as described above, is unusual. Indeed, dephosphorylation appears to precede degradation [14] , which can then proceed through the ubiquitinproteasome complex [15] (Figure 1G ).
